0 items USD 0.00Search
- Did you mean
- global intravenous thrombosis (vte)
Your search for "Global Venous thromboembolism (VTE)" gave back 219403 results.
Venous thromboembolism (VTE), which is composed of deep vein thrombosis (DVT) and pulmonary embolism (PE), is a blood clot (thrombosis) of the...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
In the context of China-US trade war and COVID-19 epidemic, it will have a big influence on this market. Venous thromboembolism (VTE) Therapeutics...
Catalog:
9Dimen Research
March 2023
Price: USD 3,200.00
Venous thromboembolism (VTE), which is composed of deep vein thrombosis (DVT) and pulmonary embolism (PE), is a blood clot (thrombosis) of the...
Catalog:
MRRPB5
April 2023
Price: USD 2,900.00
Venous thromboembolism (VTE), which is composed of deep vein thrombosis (DVT) and pulmonary embolism (PE), is a blood clot (thrombosis) of the...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
Venous thromboembolism (VTE), which is composed of deep vein thrombosis (DVT) and pulmonary embolism (PE), is a blood clot (thrombosis) of the...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Venous thromboembolism (VTE), which is composed of deep vein thrombosis (DVT) and pulmonary embolism (PE), is a blood clot (thrombosis) of the...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Venous thromboembolism (VTE), which is composed of deep vein thrombosis (DVT) and pulmonary embolism (PE), is a blood clot (thrombosis) of the...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
In the context of China-US trade war and COVID-19 epidemic, it will have a big influence on this market. Venous thromboembolism (VTE) Therapeutics...
Catalog:
9Dimen Research
September 2020
Price: USD 2,850.00
The Venous Thromboembolism (VTE) Therapeutics industry plays a crucial role in preventing and treating VTE, a condition characterized by blood clots...
Catalog:
HJResearch
June 2023
Price: USD 3,200.00
Venous thromboembolism (VTE), which is composed of deep vein thrombosis (DVT) and pulmonary embolism (PE), is a blood clot (thrombosis) of the...
Catalog:
MRRPB5
April 2023
Price: USD 2,900.00
Thromboembolism Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets Direct's...
Catalog:
Global Markets Direct
March 2022
Price: USD 2,000.00
Thromboembolism - Pipeline Review, H1 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide...
Catalog:
Global Markets Direct
January 2018
Price: USD 2,000.00
The global Rivaroxaban market size was valued at USD 8226.5 million in 2023 and is forecast to a readjusted size of USD 13960 million by 2030 with a...
Catalog:
GIR
January 2024
Price: USD 3,480.00
Rivaroxaban is an oral anticoagulant invented and manufactured by Bayer; in a number of countries it is marketed as Xarelto. In the United States, it...
Catalog:
LPI
January 2023
Price: USD 3,660.00
The global Rivaroxaban market size was valued at US$ 7821.1 million in 2023. With growing demand in downstream market, the Rivaroxaban is forecast to...
Catalog:
LPI
January 2024
Price: USD 3,660.00
